 |
HemoGenix was founded in March 2000 by Ivan N. Rich, PhD, an internationally recognized researcher in the field of developmental, experimental and applied clinical hematology, pharmaceutical industry as the only company in the world primarily specializing in stem cell hemotoxicity testing. |
|
|
|
|
|